Literature DB >> 19672575

Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT.

S E Siegelaar, E S Kilpatrick, A S Rigby, S L Atkin, J B L Hoekstra, J H Devries.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19672575      PMCID： PMC2744825          DOI： 10.1007/s00125-009-1473-x

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  11 in total

1.  Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial.

Authors:  Curt L Rohlfing; Hsiao-Mei Wiedmeyer; Randie R Little; Jack D England; Alethea Tennill; David E Goldstein
Journal:  Diabetes Care       Date:  2002-02       Impact factor: 19.112

2.  Symmetrization of the blood glucose measurement scale and its applications.

Authors:  B P Kovatchev; D J Cox; L A Gonder-Frederick; W Clarke
Journal:  Diabetes Care       Date:  1997-11       Impact factor: 19.112

3.  The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.

Authors:  Eric S Kilpatrick; Alan S Rigby; Stephen L Atkin
Journal:  Diabetes Care       Date:  2006-07       Impact factor: 19.112

4.  Mean amplitude of glycemic excursions, a measure of diabetic instability.

Authors:  F J Service; G D Molnar; J W Rosevear; E Ackerman; L C Gatewood; W F Taylor
Journal:  Diabetes       Date:  1970-09       Impact factor: 9.461

Review 5.  Structure-function interactions in the therapeutic response of diabetic neuropathy.

Authors:  A A Sima
Journal:  J Diabetes Complications       Date:  1992 Jan-Mar       Impact factor: 2.852

Review 6.  NIS-LL: the primary measurement scale for clinical trial endpoints in diabetic peripheral neuropathy.

Authors:  V Bril
Journal:  Eur Neurol       Date:  1999       Impact factor: 1.710

Review 7.  Diabetic neuropathy: a review emphasizing diagnostic methods.

Authors:  Bruce A Perkins; Vera Bril
Journal:  Clin Neurophysiol       Date:  2003-07       Impact factor: 3.708

8.  Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade?

Authors:  J Bragd; U Adamson; L B Bäcklund; P E Lins; E Moberg; P Oskarsson
Journal:  Diabetes Metab       Date:  2008-09-27       Impact factor: 6.041

9.  Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). The DCCT Research Group.

Authors: 
Journal:  Diabetes       Date:  1988-04       Impact factor: 9.461

10.  Mean blood glucose compared with HbA1c in the prediction of cardiovascular disease in patients with type 1 diabetes.

Authors:  E S Kilpatrick; A S Rigby; S L Atkin
Journal:  Diabetologia       Date:  2007-11-27       Impact factor: 10.122
View more
  34 in total

1.  Translating glucose variability metrics into the clinic via Continuous Glucose Monitoring: a Graphical User Interface for Diabetes Evaluation (CGM-GUIDE©).

Authors:  Renata A Rawlings; Hang Shi; Lo-Hua Yuan; William Brehm; Rodica Pop-Busui; Patrick W Nelson
Journal:  Diabetes Technol Ther       Date:  2011-09-20       Impact factor: 6.118

2.  Oxidative stress and glucose metabolism--is there a need to revisit effects of insulin treatment?

Authors:  P M Humpert
Journal:  Diabetologia       Date:  2010-01-06       Impact factor: 10.122

3.  Effects of glucose variability on hematopoietic stem/progenitor cells in patients with type 1 diabetes.

Authors:  F Boscari; M D'Anna; B M Bonora; S Tresso; R Cappellari; A Avogaro; D Bruttomesso; G P Fadini
Journal:  J Endocrinol Invest       Date:  2020-05-04       Impact factor: 4.256

4.  The minimum frequency of glucose measurements from which glycemic variation can be consistently assessed.

Authors:  Peter A Baghurst; David Rodbard; Fergus J Cameron
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

5.  The rise and fall of HbA(1c) as a risk marker for diabetes complications.

Authors:  E S Kilpatrick
Journal:  Diabetologia       Date:  2012-06-19       Impact factor: 10.122

Review 6.  Glycemic variability in hospitalized patients: choosing metrics while awaiting the evidence.

Authors:  Susan S Braithwaite
Journal:  Curr Diab Rep       Date:  2013-02       Impact factor: 4.810

7.  HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study.

Authors:  C C Hsu; H Y Chang; M C Huang; S J Hwang; Y C Yang; Y S Lee; S J Shin; T Y Tai
Journal:  Diabetologia       Date:  2012-08-26       Impact factor: 10.122

8.  Glucose Variability: Comparison of Different Indices During Continuous Glucose Monitoring in Diabetic Patients.

Authors:  Jean-Pierre Le Floch; Laurence Kessler
Journal:  J Diabetes Sci Technol       Date:  2016-06-28

Review 9.  Risk Factors and Comorbidities in Diabetic Neuropathy: An Update 2015.

Authors:  Nikolaos Papanas; Dan Ziegler
Journal:  Rev Diabet Stud       Date:  2015-08-10

Review 10.  The impact of glycemic variability on diabetic peripheral neuropathy.

Authors:  Heung Yong Jin; Kyung Ae Lee; Tae Sun Park
Journal:  Endocrine       Date:  2016-07-06       Impact factor: 3.633
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.